Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 54% ± 16% | |
brain | 18 studies | 32% ± 19% | |
lung | 17 studies | 35% ± 11% | |
intestine | 10 studies | 30% ± 13% | |
eye | 9 studies | 40% ± 12% | |
kidney | 7 studies | 29% ± 7% | |
liver | 6 studies | 37% ± 14% | |
lymph node | 5 studies | 48% ± 12% | |
breast | 5 studies | 35% ± 9% | |
placenta | 4 studies | 22% ± 6% | |
bone marrow | 4 studies | 41% ± 21% | |
heart | 4 studies | 26% ± 4% | |
uterus | 4 studies | 43% ± 13% | |
prostate | 4 studies | 25% ± 6% | |
adipose | 4 studies | 41% ± 17% | |
pancreas | 3 studies | 53% ± 11% | |
skin | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 18625.48 | 21 / 21 | 100% | 121.21 | 504 / 504 |
esophagus | 100% | 17647.16 | 1445 / 1445 | 100% | 141.88 | 183 / 183 |
intestine | 100% | 19307.62 | 966 / 966 | 100% | 125.54 | 527 / 527 |
liver | 100% | 9523.66 | 226 / 226 | 100% | 69.01 | 406 / 406 |
ovary | 100% | 27042.04 | 180 / 180 | 100% | 133.51 | 430 / 430 |
pancreas | 100% | 10587.18 | 328 / 328 | 100% | 106.62 | 178 / 178 |
prostate | 100% | 21838.70 | 245 / 245 | 100% | 151.47 | 502 / 502 |
skin | 100% | 16936.02 | 1809 / 1809 | 100% | 147.99 | 472 / 472 |
stomach | 100% | 14852.14 | 359 / 359 | 100% | 123.88 | 286 / 286 |
thymus | 100% | 21477.26 | 653 / 653 | 100% | 140.73 | 605 / 605 |
uterus | 100% | 22629.77 | 170 / 170 | 100% | 134.64 | 459 / 459 |
lung | 100% | 17280.69 | 578 / 578 | 100% | 123.94 | 1153 / 1155 |
breast | 100% | 20780.66 | 459 / 459 | 99% | 136.96 | 1110 / 1118 |
brain | 99% | 11925.04 | 2622 / 2642 | 100% | 161.66 | 705 / 705 |
kidney | 100% | 15056.21 | 89 / 89 | 99% | 96.62 | 894 / 901 |
adrenal gland | 100% | 14939.39 | 258 / 258 | 98% | 93.63 | 226 / 230 |
adipose | 100% | 20001.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 18237.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 156.78 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 151.06 | 29 / 29 |
muscle | 100% | 14367.15 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 25526.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 134.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 89.20 | 1 / 1 |
peripheral blood | 99% | 18433.38 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 10755.67 | 854 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030238 | Biological process | male sex determination |
GO_0000389 | Biological process | mRNA 3'-splice site recognition |
GO_0050810 | Biological process | regulation of steroid biosynthetic process |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0048662 | Biological process | negative regulation of smooth muscle cell proliferation |
GO_0033327 | Biological process | Leydig cell differentiation |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0030575 | Biological process | nuclear body organization |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005840 | Cellular component | ribosome |
GO_0089701 | Cellular component | U2AF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SF1 |
Protein name | Alternative protein SF1 Splicing factor 1, isoform CRA_b (ZFM1 protein, alternatively spliced product) Splicing factor 1 Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162) |
Synonyms | ZFM1 hCG_23378 ZNF162 |
Description | FUNCTION: Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor. . FUNCTION: Necessary for the splicing of pre-mRNA. Has a role in the recognition of the branch site (5'-UACUAAC-3'), the pyrimidine tract and the 3'-splice site at the 3'-end of introns. . FUNCTION: Necessary for the splicing of pre-mRNA. Has a role in the recognition of the branch site (5'-UACUAAC-3'), the pyrimidine tract and the 3'-splice site at the 3'-end of introns. . FUNCTION: Necessary for the splicing of pre-mRNA. Has a role in the recognition of the branch site (5'-UACUAAC-3'), the pyrimidine tract and the 3'-splice site at the 3'-end of introns. . FUNCTION: Necessary for the splicing of pre-mRNA. Has a role in the recognition of the branch site (5'-UACUAAC-3'), the pyrimidine tract and the 3'-splice site at the 3'-end of introns. . |
Accessions | F8WEG7 ENST00000448404.5 ENST00000706685.1 ENST00000681407.1 ENST00000706686.1 A0A7P0T9U7 ENST00000486867.2 A0A9L9PXR5 ENST00000334944.9 [Q15637-2] F8WEV5 ENST00000432725.1 C9J792 ENST00000413951.5 Q15637 ENST00000443908.5 ENST00000227503.13 [Q15637-4] ENST00000706684.1 H7BZT1 Q14820 A0A9L9PXE4 H7C561 H7C0N4 ENST00000377387.5 [Q15637-5] ENST00000377394.7 [Q15637-6] ENST00000413725.5 ENST00000433274.6 [Q15637-7] A0A9L9PXU0 ENST00000377390.8 [Q15637-1] L0R8E5 |